UPDATE : Thursday, October 18, 2018
Lawmakers rebuke poor follow-up steps of hypertension drug recall by Lee Hye-seon 2018-10-16 12:07
BMS to test cabiralizumab+nivolumab for pancreatic cancer by Lee Hye-seon 2018-10-11 14:23
Abbott’s hepatitis B antibody reagent recalled due to error by Lee Hye-seon 2018-10-08 15:52
Amantadine sulfate to lose indication for influenza A virus treatment by Lee Hye-seon 2018-10-08 15:49
Allergan’s eye implant recalled due to foreign substance by Lee Hye-seon 2018-10-05 13:53
BMS to start phase-3 test on oral psoriasis treatment in Korea by Lee Hye-seon 2018-10-01 15:09
Dong-A ST ordered to suspend sale of 12 drugs due to illegal rebates by Lee Hye-seon 2018-09-27 15:33
Severance, Asan violate clinical trial protocol by Lee Hye-seon 2018-09-20 11:31
Acute leukemia drug shows toxicity increase to particular genes by Lee Hye-seon 2018-09-18 14:54
AnC Bio, N&N Pharmaceuticals receive administrative warning by Lee Hye-seon 2018-09-17 14:59
Philips reports reboot error in defibrillators by Lee Hye-seon 2018-09-17 13:39
Yuhan markets high-dose copy of Agrylin by Lee Hye-seon 2018-09-14 13:42
Astellas wins nod for phase-3 trial on gastric cancer treatment by Lee Hye-seon 2018-09-11 10:38
Pfizer Korea ordered to suspend imports of 3 drugs for poor quality control by Lee Hye-seon 2018-09-07 16:24
Biopharmaceuticals lead Korea’s drug output growth by Lee Hye-seon 2018-09-07 13:47
Antihypertensive drug Kanarb tops output among local new drugs by Lee Hye-seon 2018-09-07 11:08
Antidiabetic combo Steglujan approved in Korea by Lee Hye-seon 2018-09-06 11:55
Korea to ban BPA in all food containers for children by Lee Hye-seon 2018-08-31 15:46
Myungmoon Pharm’s valsartan additionally suspended by Lee Hye-seon 2018-08-23 15:10
Lixiana faces patent challenge in substance, composition by Lee Hye-seon 2018-08-22 11:16
Back to Top